What Waterdrop Investors Missed Before The Fall

Waterdrop talked up AI tools like DeepSeek and KEYI.AI as ways to sharpen underwriting, trim costs, and lift conversion, yet shareholders saw a very different result. Holding Waterdrop from the start of the year would have meant a 44.8% loss, including dividends. If you were weighing a position on 1 January 2026, how could the mix of bullish AI promises and already weakening insurance revenues have framed that decision?

Waterdrop is not the only name tied to this theme. Zero in on 33 healthcare AI stocks and compare how each one is priced.

The Two Waterdrop Stories Investors Had To Weigh

The shares cost US$1.9 at the start of the period, and Waterdrop sat between two sharply different stories about where AI and regulation might leave the business.

On the upbeat side, the bull Narrative saw new tools like DeepSeek lifting sales efficiency. It described a Fair Value of US$2.21 as the price implied if revenue grew 15.1% and profit margins reached 15.2% over three years.

The bear Narrative pointed to stricter Chinese regulation and demographic pressure. It described a Fair Value of US$1.36 and a concern that compliance costs could steadily erode profitability.

What The Results Changed For The Waterdrop AI Story

Waterdrop’s 2025 ESG report put KEYI.AI and AI underwriting efficiency in the spotlight, which supported the view that technology could improve operations. The later Q2 2026 figures told a tougher tale. Revenue reached CNY 1,448.219m versus CNY 837.959m, yet net income slipped to CNY 125.772m and margin fell to 8.7%. The evidence pointed in both directions.

The key assumption was that AI would lift profitability, not just scale. When you assess a similar pitch elsewhere, compare any AI or efficiency claim with the trend in net margin and absolute earnings, not just top-line growth.

What You Are Paying For In Waterdrop Today

Waterdrop trades at US$1.01 today, after a share price that declined 44.8% from the start of the year. The selected Narrative still places its Fair Value above that level and anchors the case on how AI driven tools might shape revenue quality and operating resilience across several lines of business.

That view leans on AI agents, heavy traffic spending and clinical trial services feeding into stable margins over time. A buyer today would be judging whether that ongoing AI and user acquisition investment can sustain durable customer relationships without letting marketing and technology costs absorb most of the profit pool.

"The main thing that has to go right is that Waterdrop continues to convert heavy investment in AI, traffic and user acquisition into durable customer relationships and stable operating margins. The current valuation implies the market is not fully pricing in Waterdrop's record of 18 consecutive profitable quarters, AI patent portfolio and ongoing dividends and share repurchases."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

How Could You Get There Earlier?

The next headline does not have to be where your research begins. Go straight to the companies and see whether a contrarian opportunity could be taking shape.

• Company 1 - 30% below our estimate - sells coconut based drinks as retailers broaden shelf space and private label demand.
• Company 2 - 47% below our estimate - refocuses on higher margin engine services while integrating a large aviation acquisition.
• Company 3 - 48% below our estimate - tackles record infrastructure backlog while rising labor and tech spending strain project margins.

Those are three of them. See all 33 potentially undervalued companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com